Literature DB >> 1396683

Stoichiometry of interaction between interferon gamma and its receptor.

M Fountoulakis1, M Zulauf, A Lustig, G Garotta.   

Abstract

The biological response of interferon gamma is mediated by binding to a specific cell-surface receptor. We investigated the stoichiometry of this binding using soluble receptors produced in prokaryotic and eukaryotic expression systems comprising the extracellular ligand-binding domain of the native protein. The ligand-receptor complexes were analyzed by cross-linking, chromatography, analytical ultracentrifugation and laser-light scattering. Cross-linking and chromatography showed that the stoichiometry of the interaction between ligand and receptor depends on the molar ratios of the two components mixed. All approaches confirmed that mixtures of ligand-receptor complexes are formed with one interferon-gamma dimer bound by one or two receptors. The soluble receptor produced in Escherichia coli mainly showed a ligand/receptor stoichiometry of 1:1, while the receptors produced in eukaryotic cells showed a stoichiometry of binding of 1:2. This apparent discrepancy is most likely due to the conformational heterogeneity of the Escherichia-coli-derived protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396683     DOI: 10.1111/j.1432-1033.1992.tb17248.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  18 in total

1.  Identification and functional characterization of a second chain of the interleukin-10 receptor complex.

Authors:  S V Kotenko; C D Krause; L S Izotova; B P Pollack; W Wu; S Pestka
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

2.  Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation.

Authors:  P Najarro; P Traktman; J A Lewis
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Interaction of truncated human interferon gamma variants with the interferon gamma receptor: crucial importance of Arg-129.

Authors:  J Haelewyn; L Michiels; P Verhaert; M F Hoylaerts; R Witters; M De Ley
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

4.  Engineering of a functional interleukin-5 monomer: a paradigm for redesigning helical bundle cytokines with therapeutic potential in allergy and asthma.

Authors:  R R Dickason; J D English; D P Huston
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

5.  Radiation inactivation of human gamma-interferon: cellular activation requires two dimers.

Authors:  J A Langer; A Rashidbaigi; G Garotta; E Kempner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

Review 6.  Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity.

Authors:  Elise Alspach; Danielle M Lussier; Robert D Schreiber
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-03-01       Impact factor: 10.005

7.  Crystal structure of the interferon gamma receptor alpha chain from chicken reveals an undetected extra helix compared with the human counterparts.

Authors:  Zhiguang Ping; Jianxun Qi; Yanling Sun; Guangwen Lu; Yi Shi; Xiaojia Wang; George F Gao; Ming Wang
Journal:  J Interferon Cytokine Res       Date:  2013-11-27       Impact factor: 2.607

8.  Ligand-induced assembly and activation of the gamma interferon receptor in intact cells.

Authors:  E A Bach; J W Tanner; S Marsters; A Ashkenazi; M Aguet; A S Shaw; R D Schreiber
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

Review 9.  Oligodendroglial response to the immune cytokine interferon gamma.

Authors:  B Popko; K D Baerwald
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

10.  IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses.

Authors:  Shana M Coley; Mandy L Ford; Samantha C Hanna; Maylene E Wagener; Allan D Kirk; Christian P Larsen
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.